Start-Ups in Brief (5/04)
In Vivo Europe Rx briefly summarizes the technologies of Exeter Antioxidant Therapeutics Ltd., ProteinLogic Ltd., Pronas Pharma, and Quattro Research GMBH.
You may also be interested in...
In Vivo's editors pick January's most significant deals, including Roche's acquisition of Flatiron and Moderna's latest big private fundraising. (Free article.)
In Vivo's editors pick January's most significant deals, including an alliance of players new to health care and Celgene's big buys. (Free article.)
We nominated 15 deals in three categories. You picked the winners.